Details for New Drug Application (NDA): 065048
✉ Email this page to a colleague
The generic ingredient in CEFUROXIME SODIUM is cefuroxime sodium. There are sixty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cefuroxime sodium profile page.
Summary for 065048
Tradename: | CEFUROXIME SODIUM |
Applicant: | Hikma |
Ingredient: | cefuroxime sodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 065048
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CEFUROXIME SODIUM | cefuroxime sodium | INJECTABLE;INJECTION | 065048 | ANDA | Hikma Pharmaceuticals USA Inc. | 0143-9567 | 0143-9567-25 | 25 VIAL in 1 CARTON (0143-9567-25) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0143-9567-01) |
CEFUROXIME SODIUM | cefuroxime sodium | INJECTABLE;INJECTION | 065048 | ANDA | Hikma Pharmaceuticals USA Inc. | 0143-9568 | 0143-9568-25 | 25 VIAL in 1 CARTON (0143-9568-25) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0143-9568-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | Strength | EQ 750MG BASE/VIAL | ||||
Approval Date: | Jan 9, 2004 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1.5GM BASE/VIAL | ||||
Approval Date: | Jan 9, 2004 | TE: | AP | RLD: | No |
Complete Access Available with Subscription